Cancer and Cardiothoracic - Cardiovascular Update

Study reveals mechanism linking heart disease to cancer development

Medical Xpress - Cardiology

APRIL 9, 2024

Researchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism responsible for increasing the risk of developing cancer among patients with heart disease: Small extracellular bubbles, or vesicles (sEVs), secreted from the sick heart to heal itself, are released into the (..)

Cancer

Cancer Heart Disease Cardiothoracic Research

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

Society of Thoracic Surgeons - Adult Cardiac

JANUARY 26, 2025

The CHSD is part of the STS National Database, one of the largest and most comprehensive clinical registries with nearly 10 million cardiothoracic procedures performed by 4,300+ surgeons. The Societys mission is to improve the lives of patients with cardiothoracic diseases.

Aortic valve

Aortic valve Cardiothoracic Congenital Aortic

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement, said Michael Bowdish, MD, lead author of the study and a cardiothoracic surgeon at Cedars-Sinai Medical Center in Los Angeles.

Aortic valve

Aortic valve Aortic Cardiothoracic Cancer

Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2025

Recent advances in immunotherapy have significantly improved outcomes for cancer patients. However, therapies such as immune checkpoint inhibitors (ICIs) can lead to immune-related adverse events, including potentially fatal ICI-myocarditis.

Cardiothoracic

Cardiothoracic Cancer Outcomes

Effects of respiratory sarcopenia on the postoperative course in elderly lung cancer patient: a retrospective study

Journal of Cardiothoracic Surgery

JANUARY 17, 2025

Recently, sarcopenia has been linked to unfavorable outcomes in various surgical procedures, including lung cancer surgery. This study aimed to investigate the impact of respiratory sarcopenia (RS) on postoper.

Cancer

Cancer Outcomes Research

LncRNA CASC9 facilitates papillary thyroid cancer development and doxorubicin resistance via miR-28-3p/BCL-2 axis and PI3K/AKT signaling pathway

Journal of Cardiothoracic Surgery

NOVEMBER 12, 2024

Papillary thyroid cancer (PTC) is a malignant tumor that poses a serious threat to human health. LncRNA CASC9 serves as an oncogene in numerous tumors. The purpose of this study was to explore the mechanism of.

Cancer

Cancer Research

Surgeon Preference Impacts Survival Outcomes Analyses for CABG Patients

DAIC

JANUARY 24, 2025

Our analysis provides new insights on an important clinical questionwhether CABG with multiple arteries used as a conduit, rather than one artery and veins from the leg, may benefit patients by improving their long-term survival, said lead study author Justin Schaffer, MD, a cardiothoracic surgeon at Baylor Scott & White Health in Plano, Texas.

Outcomes

Outcomes Coronary Artery Bypass Graft Cardiothoracic Medicare

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

APRIL 30, 2024

As cardiothoracic surgery continues to evolve, STS has responded by adding new risk models to guide treatment decisions and benchmark performance,” said STS President Jennifer C. With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the U.S.,

TAVR

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

JANUARY 29, 2024

The conference, healthcare’s leading scientific and educational convening specializing in cardiothoracic surgery, has a rich history of showcasing clinical trials with a strong foundation of detailed methodology and trusted data collection governed by ethical clinical principles.

Research

Research TAVR Aortic valve Atrial Fibrillation

The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging system

Journal of Cardiothoracic Surgery

APRIL 9, 2024

The 8th edition lung cancer staging system was the first to describe the detailed diagnosis and staging of multiple primary lung cancers (MPLC). However, the characteristics and prognosis of MPLC categorized a.

Cancer

Cancer Research

Management and outcomes of thoracic sarcomas - a collaboration between Orthopaedic Oncology and cardiothoracic surgery: seven-year clinical data from a tertiary referral centre

Journal of Cardiothoracic Surgery

JANUARY 26, 2025

Sarcomas are rare cancers originating from mesenchymal tissues, manifesting in diverse anatomical locations, but notably in connective tissue, muscles and the skeleton. Thoracic sarcomas present a unique diagn.

Cardiothoracic

Cardiothoracic Cancer Outcomes Research

Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer

Journal of Cardiothoracic Surgery

FEBRUARY 3, 2024

Early-stage esophageal cancer is treated using endoscopic submucosal dissection and esophagectomy. Field cancerization in patients with early-stage esophageal cancer affects treatment outcomes and causes synch.

Cancer

Cancer Outcomes Research

POLR1D silencing suppresses lung cancer cells proliferation and migration via inhibition of PI3K-Akt pathway

Journal of Cardiothoracic Surgery

JUNE 5, 2024

The most common type of cancer that leads to death worldwide is lung cancer. Despite significant surgery and chemotherapy improvements, lung cancer patient’s survival rate is still poor. The RNA polymerase I s.

Cancer

Cancer Research

Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer

Journal of Cardiothoracic Surgery

SEPTEMBER 19, 2024

Lung cancer accounts for a significant proportion of cancer-related deaths in China, with the majority of the cases being classified as non-small cell lung cancer (NSCLC). The study aimed to investigate the ex.

Cancer

Cancer Research

Prognostic role of CRABP2 in lung cancer: a meta-analysis

Journal of Cardiothoracic Surgery

JUNE 23, 2024

The prognostic value of cellular retinoic acid-binding protein 2 (CRABP2), in lung cancer patients remains to be uncertained. Therefore, our research attempted to assess the relationship between CRABP2 and sur.

Cancer

Cancer Research

Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?

Journal of Cardiothoracic Surgery

JANUARY 22, 2025

Lung cancer is the leading cause of cancer-related deaths worldwide. Therefore, the search for new biomarkers continues in order to diagnose lung cancer at an early stage. In this study, we investigated blood.

Cancer

Cancer Biomarkers Research

Research progress on the association between lung cancer and pulmonary embolism

Journal of Cardiothoracic Surgery

JANUARY 2, 2025

Pulmonary embolism (PE), a form of venous thromboembolism, is a frequently observed complication in malignancies, with a notably high incidence in individuals with lung cancer. The presence of PE markedly redu.

Embolism

Embolism Cancer Pulmonary Research

Clinical value of measuring plasma D-dimer levels in patients with esophageal cancer

Journal of Cardiothoracic Surgery

JUNE 21, 2024

Esophageal cancer represents a significant public health concern; however, reliable diagnostic and prognostic markers have not been established. This study aimed to investigate the clinical value of plasma D-d.

Cancer

Cancer Public Health Research

Awake thoracic surgery for lung cancer treatment: where we are and future perspectives—our experience and review of literature

Journal of Cardiothoracic Surgery

JANUARY 12, 2025

Lung cancer is the first cause of cancer-related death. Awake lung resection is a new frontier of the concept of minimally invasive surgery. Our purpose is to demonstrate the feasibility of this technique for.

Cancer

Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study

Journal of Cardiothoracic Surgery

AUGUST 1, 2024

Combining pemetrexed with bevacizumab may have some potential in improving the efficacy in patients with non-small-cell lung cancer (NSCLC), and this meta-analysis aims to explore the impact of pemetrexed addi.

Cancer

Cancer Research

Surgical intervention for lung cancer in patients aged 75 and above: potential associations with increased mortality rates—a single-center observational study

Journal of Cardiothoracic Surgery

JULY 28, 2024

Lung cancer, which is diagnosed two to three times more frequently in patients over the age of 70, is a leading cause of cancer-specific mortality. Given the elevated risk of morbidity and mortality, surgical.

Cancer

Cancer Research

A causal association between chemokines and the risk of lung cancer: a univariate and multivariate mendelian randomization study

Journal of Cardiothoracic Surgery

NOVEMBER 7, 2024

Observational studies and experimental evidence have shown that chemokines play important roles in lung cancer development, progression, and treatment. However, few studies have examined the causal association.

Cancer

Cancer Research

The correlation between miR-21 single nucleotide polymorphisms and the susceptibility of non-small cell lung cancer

Journal of Cardiothoracic Surgery

JANUARY 19, 2025

There are still gaps in the study of the miRNA and its SNPs in some diseases such as non-small cell lung cancer (NSCLC). The study aimed to provide useful information on the treatment of NSCLC by investigating.

Cancer

Cancer Research

Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients

Journal of Cardiothoracic Surgery

JUNE 23, 2024

To explore the independent predictors of pathological mediastinal lymph node (pN2) metastasis in clinical stage IA (cIA) pure-solid non-small cell lung cancer (NSCLC) patients, and to find an appropriate metho.

Cancer

Cancer Research

MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis

Journal of Cardiothoracic Surgery

DECEMBER 22, 2024

The regulatory role of the miR-618/JAK2/STAT3 axis in non-small cell lung cancer cells (NSCLC) was investigated with the objective of identifying a target for the precise treatment of patients with NSCLC.

Cancer

Cancer Research

Survival outcomes of segmentectomy and lobectomy for early stage non-small cell lung cancer: a systematic review and meta-analysis

Journal of Cardiothoracic Surgery

JUNE 21, 2024

The question of whether segmentectomy and lobectomy have similar survival outcomes for patients with early-stage non-small cell lung cancer (NSCLC) is a matter of debate.

Cancer

Cancer Outcomes

Prognostic significance of CEA reduction rate in patients with abnormally high preoperative CEA levels who underwent surgery for lung cancer

Journal of Cardiothoracic Surgery

DECEMBER 19, 2024

The aim of this research was to investigates the prognostic importance of change in carcinoembryonic antigen (CEA) levels (particularly abnormal high concentration) in patients with non-small cell lung cancer.

Cancer

Cancer Research

Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: a randomized controlled trial

Journal of Cardiothoracic Surgery

JANUARY 19, 2025

To assess the effectiveness and safety profiles of rivaroxaban compared to low molecular weight heparin (LMWH) in managing lower extremity deep vein thrombosis (DVT) subsequent to thoracoscopic lung cancer sur.

Thrombosis

Thrombosis Cancer Research

The Surgeon’s Role in Managing Patients with Resectable NSCLC

Society of Thoracic Surgeons - Surgeon

MARCH 8, 2024

Video The Surgeon’s Role in Managing Patients with Resectable NSCLC smccarthy Fri, 03/08/2024 - 14:51 In this video, Dr. Leah Backhus, thoracic surgeon and professor of cardiothoracic surgery at Stanford Medicine, discusses the surgeon’s role in managing patients with resectable non-small cell lung cancer.

Cardiothoracic

Cardiothoracic Biomarkers Cancer

Long-term outcomes of surgical treatment of non-small cell lung cancer with oligometastatic disease involving only the brain in the era of PET/CT

Journal of Cardiothoracic Surgery

DECEMBER 19, 2024

The prognosis of patients with synchronous oligometastatic non-small cell lung cancer (NSCLC) has been improving owing to advancements in imaging techniques and new treatment approaches such as tyrosine kinase.

Cancer

Cancer Outcomes Research

One case of surgical treatment of coagulation factor XI deficiency complicated with esophageal cancer: a case report

Journal of Cardiothoracic Surgery

FEBRUARY 1, 2024

It usually occurs after surgery or trauma; Esophageal cancer is a common malignant tumor of the digestive tra. Coagulation factor XI deficiency is an autosomal recessive hereditary disease with a low incidence.

Cancer

8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC

Society of Thoracic Surgeons - Surgeon

MAY 23, 2024

Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer. The Society’s 8 in 8 Series offers quick access to important topics in cardiothoracic surgery. Supported by AstraZeneca.

Biomarkers

Biomarkers CME Cardiothoracic Cancer

Durvalumab supplementation for non-small-cell lung cancer: a meta-analysis study

Journal of Cardiothoracic Surgery

JULY 3, 2024

Durvalumab supplementation may have some potential in improving the efficacy in patients with non-small-cell lung cancer (NSCLC), and this meta-analysis aims to explore the impact of durvalumab supplementation.

Cancer

Cancer Research

Therapeutic effect of induction therapy including nab-paclitaxel followed by surgical resection for the patients with locally advanced non-small-cell lung cancer

Journal of Cardiothoracic Surgery

JULY 4, 2024

Lung cancer is associated with a high mortality rate worldwide. Non-small-cell lung cancer (NSCLC) is a major subtype of lung cancer. Carboplatin (CBDCA) plus nab-paclitaxel (PTX) has become a standard treatme.

Cancer

Cancer Research

Simultaneous bilateral video-assisted thoracic surgery is safe and feasible for multiple primary lung cancers

Journal of Cardiothoracic Surgery

JULY 11, 2024

The treatment for bilateral synchronous multiple primary lung cancers (MPLC) remains challenging. Simultaneous bilateral video-assisted thoracic surgery (VATS) may be an optimal treatment with curative intent,

Cancer

Cancer Research

The clinical effect of thoracoscopic segmentectomy in the treatment of lung malignancies less than 2CM in diameter

Journal of Cardiothoracic Surgery

OCTOBER 28, 2024

In this retrospective study, a total of 103 patients with lung cancer who received outpatient or inpatient treatment from December 2020 to May 2022 were selected and divided into the lobectomy group (n = 48) and the segmentectomy group (n = 55) according to different surgical methods. interquartile range, 14.8–21.3)

Quality of Life

Quality of Life Cancer Outpatient Inpatient

Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy

Journal of Cardiothoracic Surgery

MARCH 10, 2024

The basis for current and future lung cancer immunotherapy depends on our knowledge of molecular mechanisms of interactions between tumor and immune system cells. Interactions that occur between different intr.

Cancer

Cancer Research

Robotic-assisted right upper lobectomy with systemic pulmonary vein anomaly: a case report

Journal of Cardiothoracic Surgery

JANUARY 2, 2024

While the role of low-dose computed tomography (CT) in lung cancer screening is established, its limitations in detailing pulmonary vascular variations are less emphasized. Three-dimensional reconstruction tec.

Pulmonary

Pulmonary Cancer

Preserve Medical Research Funding

Society of Thoracic Surgeons - Research

FEBRUARY 5, 2024

Advocating for cardiothoracic specific programs : including the National Heart, Lung, and Blood Institute (NHLBI) at the NIH.

Research

Research Cancer Cardiothoracic Innovation

The Evolving Computed Tomography Market

DAIC

MARCH 7, 2024

A 2021 study published in Radiology: Cardiothoracic Imaging focused on cardiac imaging trends over a decade. According to the company, the Duo system adds high resolution thoracic clinical capability, suitable for screening lung cancer, COVID-19 and other pulmonary diseases.

Technology

Technology Document Cardiovascular Imaging Cancer

Clinical significance of postoperative thrombocytosis after vats lobectomy for NSCLC

Journal of Cardiothoracic Surgery

SEPTEMBER 13, 2024

Thrombocytosis is a clinical condition generally associated with poor prognosis in patients with cancer. Thrombocytosis may be present after lung cancer resection, but the clinical significance of thrombocytos.

Cancer

Cancer Research

Anomalous drainage of lingular vein into left inferior pulmonary vein during thoracoscopic lung cancer surgery

Journal of Cardiothoracic Surgery

JANUARY 6, 2025

The intricate anatomical variations in lung structure often perplex thoracic surgeons, and the accurate identification of these variations is closely associated with favorable surgical outcomes.

Cancer

Cancer Pulmonary Outcomes

A case of lung metastasis from gastric cancer presenting as ground-glass opacity dominant nodules

Journal of Cardiothoracic Surgery

JUNE 23, 2024

Most metastatic lung tumors present as solid nodules on chest computed tomography (CT). In contrast, ground-glass opacity on chest computed tomography usually suggests low-grade malignant lesions such as adeno.

Cancer

Surgeon Preference Factors into Survival Outcomes Analyses for Multi- and Single-Arterial Bypass Grafting

Society of Thoracic Surgeons - Congenital

JANUARY 7, 2025

Our analysis provides new insights on an important clinical questionwhether CABG with multiple arteries used as a conduit, rather than one artery and veins from the leg, may benefit patients by improving their long-term survival, said lead study author Justin Schaffer, MD, a cardiothoracic surgeon at Baylor Scott & White Health in Plano, Texas.

Outcomes

Outcomes Cardiothoracic Coronary Artery Bypass Graft Medicare

Study reveals mechanism linking heart disease to cancer development

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case

Effects of respiratory sarcopenia on the postoperative course in elderly lung cancer patient: a retrospective study

LncRNA CASC9 facilitates papillary thyroid cancer development and doxorubicin resistance via miR-28-3p/BCL-2 axis and PI3K/AKT signaling pathway

Surgeon Preference Impacts Survival Outcomes Analyses for CABG Patients

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging system

Management and outcomes of thoracic sarcomas - a collaboration between Orthopaedic Oncology and cardiothoracic surgery: seven-year clinical data from a tertiary referral centre

Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer

POLR1D silencing suppresses lung cancer cells proliferation and migration via inhibition of PI3K-Akt pathway

Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer

Prognostic role of CRABP2 in lung cancer: a meta-analysis

Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?

Research progress on the association between lung cancer and pulmonary embolism

Clinical value of measuring plasma D-dimer levels in patients with esophageal cancer

Awake thoracic surgery for lung cancer treatment: where we are and future perspectives—our experience and review of literature

Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study

Surgical intervention for lung cancer in patients aged 75 and above: potential associations with increased mortality rates—a single-center observational study

A causal association between chemokines and the risk of lung cancer: a univariate and multivariate mendelian randomization study

The correlation between miR-21 single nucleotide polymorphisms and the susceptibility of non-small cell lung cancer

Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients

MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis

Survival outcomes of segmentectomy and lobectomy for early stage non-small cell lung cancer: a systematic review and meta-analysis

Prognostic significance of CEA reduction rate in patients with abnormally high preoperative CEA levels who underwent surgery for lung cancer

Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: a randomized controlled trial

The Surgeon’s Role in Managing Patients with Resectable NSCLC

Long-term outcomes of surgical treatment of non-small cell lung cancer with oligometastatic disease involving only the brain in the era of PET/CT

One case of surgical treatment of coagulation factor XI deficiency complicated with esophageal cancer: a case report

8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC

Durvalumab supplementation for non-small-cell lung cancer: a meta-analysis study

Therapeutic effect of induction therapy including nab-paclitaxel followed by surgical resection for the patients with locally advanced non-small-cell lung cancer

Simultaneous bilateral video-assisted thoracic surgery is safe and feasible for multiple primary lung cancers

The clinical effect of thoracoscopic segmentectomy in the treatment of lung malignancies less than 2CM in diameter

Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy

Robotic-assisted right upper lobectomy with systemic pulmonary vein anomaly: a case report

Preserve Medical Research Funding

The Evolving Computed Tomography Market

Clinical significance of postoperative thrombocytosis after vats lobectomy for NSCLC

Anomalous drainage of lingular vein into left inferior pulmonary vein during thoracoscopic lung cancer surgery

A case of lung metastasis from gastric cancer presenting as ground-glass opacity dominant nodules

Surgeon Preference Factors into Survival Outcomes Analyses for Multi- and Single-Arterial Bypass Grafting

Stay Connected